Shari Anne El-Dash Lamy

Shari Anne El-Dash Lamy

Auto-generated profile, based on publicly available information

Shari Anne El-Dash Lamy

A.C. Camargo Cancer Center

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
ENElnara Marcia Negri
Elnara Marcia Negri
BPBruna Mamprim Piloto
Bruna Mamprim Piloto
LMLuciana Kato Morinaga
Luciana Kato Morinaga
CJCarlos Viana Poyares Jardim
Carlos Viana Poyares Jardim
SLShari Anne El-Dash Lamy
Shari Anne El-Dash Lamy
DDDaniel Deheinzelin
Daniel Deheinzelin
INTRODUCTION: Elevated D-dimer is a predictor of severity and mortality in COVID-19 patients and heparin use during in-hospital stay has been associated with decreased mortality. COVID-19 patient autopsies have revealed thrombi in the microvasculature, suggesting intravascular coagulation as a prominent feature of organ failure in these patients. Interestingly, in COVID-19, pulmonary compliance is preserved despite severe hypoxemia corroborating the hypothesis that perfusion mismatch may play a significant role in the development of respiratory failure. METHODS: We describe a series of 27 consecutive COVID-19 patients admitted to Sirio-Libanes Hospital in São Paulo-Brazil and treated with heparin in therapeutic doses tailored to clinical severity. RESULTS AND DISCUSSION: PaO2/FiO2 ratio increased significantly over the 72 hours following the start of anticoagulation, from 254(±90) to 325(±80), p=0.013, and 81% of the patients were discharged home within a mean time of 11.4 (±7.9) days. Most mechanically ventilated patients (67%) were extubated within 12.5(± 5.7) days. There were no bleeding complications or fatal events. Even though this uncontrolled case series does not offer absolute proof of DIC as the underlying mechanism of respiratory failure in COVID-19, patient’s positive response to tailored dose heparinization contributes to the understanding of the pathophysiological mechanism of the disease and provides valuable information for the treatment of these very sick patients while we await the results of further prospective controlled studies.